INTERNATIONAL PATENT: IRONWOOD PHARMACEUTICALS, INC. FILES APPLICATION FOR "COMBINATIONS OF GLP-1 AND GUANYLATE CYCLASE C (GC-C) RECEPTOR AGONISTS"

GENEVA, March 11 -- IRONWOOD PHARMACEUTICALS, INC. (100 Summer StreetSuite 2300Boston, Massachusetts 02110) filed a patent application (PCT/US2025/043458) for "COMBINATIONS OF GLP-1 AND GUANYLATE CYCLASE C (GC-C) RECEPTOR AGONISTS" on Aug 26, 2025. With publication no. WO/2026/050206, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): CURRIE, Mark G. (197 8th Street, PH21Boston, Massachusetts 02129)

Abstract: The present disclosure provides combinations of GLP-1 receptor agonists, and guanylate-cyclase C (GC-C) receptor ago...